Insider Stock Trading History of Henwood Geraldine


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Henwood Geraldine since year 2005. The trader's CIK number is 1236451. At the time of this reporting, Henwood Geraldine is the President and CEO of Recro Pharma, Inc. . (stock ticker symbol REPH). See this page for all insider trading activities at Recro Pharma, Inc. .

Note that in the past HENWOOD GERALDINE also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Henwood Geraldine since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-09-28 REPH Recro Pharma, Inc. Option Ex 31,100 .00 0
2015-06-05 REPH Recro Pharma, Inc. Buy 3,950 8.83 34,878
2015-06-08 REPH Recro Pharma, Inc. Buy 550 9.56 5,258
2014-01-15 ALKS Alkermes Plc. Sale 40,000 47.90 1,916,120
2014-01-15 ALKS Alkermes Plc. Option Ex 40,000 15.40 616,200
2013-08-29 ALKS Alkermes Plc. Sale 20,000 31.68 633,540
2013-08-29 ALKS Alkermes Plc. Option Ex 20,000 13.44 268,800
2013-02-28 MAPP Map Pharmaceuticals, Inc. Option Ex 10,000 11.94 119,400
2013-02-28 MAPP Map Pharmaceuticals, Inc. Sale 10,000 25.00 250,000
2012-11-23 MAPP Map Pharmaceuticals, Inc. Option Ex 5,240 1.96 10,270
2012-11-23 MAPP Map Pharmaceuticals, Inc. Sale 5,240 15.00 78,600
2012-08-24 ALKS Alkermes Plc. Option Ex 20,000 11.84 236,800
2012-08-24 ALKS Alkermes Plc. Sale 20,000 17.94 358,840
2012-08-27 ALKS Alkermes Plc. Option Ex 20,000 11.44 228,800
2012-08-27 ALKS Alkermes Plc. Sale 20,000 17.80 355,980
2012-02-22 ALKS Alkermes Plc. Option Ex 46,400 9.60 445,440
2012-02-23 ALKS Alkermes Plc. Option Ex 1,600 8.98 14,368
2012-02-22 ALKS Alkermes Plc. Sale 46,400 17.29 802,070
2012-02-23 ALKS Alkermes Plc. Sale 1,600 17.32 27,704
2010-10-27 MAPP Map Pharmaceuticals, Inc. Sale 9,764 15.66 152,884
2010-10-27 MAPP Map Pharmaceuticals, Inc. Option Ex 9,764 1.52 14,860
2010-08-05 MAPP Map Pharmaceuticals, Inc. Option Ex 12,000 .74 8,916
2010-08-05 MAPP Map Pharmaceuticals, Inc. Sale 12,000 12.78 153,408
2009-11-18 MAPP Map Pharmaceuticals, Inc. Option Ex 16,250 .64 10,416
2009-11-18 MAPP Map Pharmaceuticals, Inc. Sale 16,250 8.77 142,447
2006-03-10 AUXL Auxilium Pharmaceuticals Inc Buy 1,000 6.43 6,430

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Henwood Geraldine (President and CEO of Recro Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.